Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

FORGOTTEN HISTORY: 5 | History Defined

How to nominate an executive for the 2023 Fortune Most Powerful Women list

The 2023 Fortune Most Powerful Women in Business list will publish this fall.

Fortune

5 Special Situation Stocks for Growth & Income

Special situation stocks create event-driven opportunities for investors. Here are five that are worth a closer look.

Kiplinger

Can the most powerful woman on the Fortune 500 fix our broken health care system?

CVS CEO Karen Lynch holds immense power as the leader of one of the biggest health care companies. What is she doing with it?

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

CVS Health (CVS) vs. MedAvail Holdings (MDVL): Which Is the Better Buy?

The drug store industry is well positioned for long-term growth thanks to the growing demand for prescription drugs. Let’s compare CVS Health (CVS) and MedAvail (MDVL) in this space to determine which is better positioned to capitalize on the industry’s solid growth prospects….

StockNews.com

Companies like CVS and UnitedHealth are now some of the world’s biggest businesses. Is that healthy for the rest of us?

The companies and their rivals say their enormous size and scope makes them the best candidates to fix America’s health care system. After a new wave of mergers, they're under pressure to prove it.

Fortune

The real cost of the ‘supermom’ myth. Here’s the toll motherhood takes on your mental health

Many women with postpartum health conditions fear their conflicting feelings about motherhood make them less fit to be a good mother.

Fortune

Healthcare Consolidation: 3 Stocks That Saw Mergers and Acquisitions

The healthcare industry is expected to see increased M&A activity this year, fueled by ample cash reserves and private equity dry powder. Investors could take advantage of this trend by investing in fundamentally sound healthcare stocks UnitedHealth (UNH), Elevance Health (ELV), and CVS Health (CVS). Continue reading….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

CVS Health CEO Karen Lynch wants better care for new moms at risk of postpartum depression

The CEO sees a connection between mind and body.

Fortune

The ‘war on science’ is hurting our health. These leaders are fighting back

Americans’ lack of trust in healthcare was perhaps the biggest issue plaguing leaders and healthcare professionals at Fortune’s Brainstorm Health conference this week.

Fortune

CVS vs. Walgreens: Which Is the Better Stock to Own?

The retail pharmacy industry has evolved in recent years and is predicted to continue experiencing strong growth. This should benefit pharma stocks, CVS Health (CVS), and Walgreens Boots (WBA). But which is the better stock to own? Read more to find out.

StockNews.com

3 Stocks You Shouldn’t Hesitate to Buy Despite Rising Recession Risks

The bank failures and the Fed’s monetary tightening have increased the risk of a recession later this year. This is expected to keep the stock market under pressure. Amid this uncertainty, it could be wise to buy and hold fundamentally strong stocks Oracle (ORCL), CVS Health (CVS), and Humana (HUM)…

StockNews.com

3 Great Stocks to Buy and Hold Until You Retire

The recent banking turmoil caused by high-profile bank failures, renewed recession fears, and uncertainty over the Fed’s next move have significantly affected investor sentiment. Amid an uncertain market backdrop, it could be wise to buy and hold fundamentally sound, dividend-paying stocks Oracle Corporation (ORCL), CVS Health (CVS), and Humana (HUM)…

StockNews.com

Nearly half of working mothers have been diagnosed with anxiety or depression. Here’s what can help

The country’s working moms are facing a mental health crisis.

Fortune

CEO Karen Lynch says CVS's acquisition spree will make health care simpler and more affordable

The pharmacy chain is in the process of buying Signify and Oak Street Health.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Why CVS Health CEO Karen Lynch wore a 'taking up space' T-shirt on her first day

As CVS starts offering primary care services, the CEO talks full-service health care.

StockNews.com

2 Stocks on Track for Massive Gains in 2023

While Federal Reserve Chair Jerome Powell is trying to steer the economy toward a ‘soft landing,’ a strong job market will likely keep the Fed wary. Meanwhile, as investors mull over the Fed’s next steps, the market could remain volatile for some time. Hence, investing in fundamentally sound stocks, CVS…

Chicago Tribune

CVS buying Chicago’s Oak Street Health in deal valued at $10.6 billion

CHICAGO — CVS Health plans to buy Chicago-based Oak Street Health in a $10.6 billion deal that aims to expand CVS’s reach into primary care.

StockNews.com

3 Winning Stocks to Buy No Matter What the Market Does

Continuing improvements in economic indicators reflect that the U.S. economy is resilient amid the weak earnings forecasts. However, since the market is expected to remain under pressure for some time, it could be wise to add winning stocks, Oracle Corp. (ORCL), CVS Health (CVS), and Halliburton (HAL), to your portfolio.…

Get all your
news in one place.

100's of premium titles.
One news app.

Chicago Sun-Times

CVS buys Chicago-based Oak Street Health for $10.6B

Oak Street Health runs primary care centers mostly for lower-to-middle income people with Medicare Advantage plans.

The Independent UK

CVS acquires Oak Street primary care for $10.6 billion

CVS Health is plunging deeper into providing primary care with an approximately $10.6 billion deal to acquire Oak Street Health

StockNews.com

Owning These 3 Stocks Could Make You Rich in 10 Years

Consistently falling prices and stronger-than-expected fourth-quarter GDP are renewing hopes about the economy’s overall health. Therefore, it could be wise to add quality stocks with solid fundamentals, Walmart (WMT), Bristol-Myers Squibb (BMY), and CVS Health (CVS), to your portfolio to garner substantial returns in 10 years. Read more….

StockNews.com

5 Unstoppable Stocks You Shouldn't Wait Any Longer to Buy

The Fed’s intention to keep raising interest rates despite the cooling down of inflation could eventually lead to the economy witnessing a recession. Moreover, the World Bank lowered its 2023 global growth forecast by almost half, citing deteriorating economic conditions. Hence, it could be wise to invest in fundamentally sound…

StockNews.com

3 Hyper-Growth Stocks to Buy for Big Gains

With recent economic data showing promise, the chances of a soft landing for the economy are increasing. Hence, it could be wise to invest in fundamentally sound stocks CVS Health (CVS), Ooma (OOMA), and Neurocrine Biosciences (NBIX), which possess solid growth attributes. Read on….

StockNews.com

3 Health Care Stocks That Could Help You Make a Fortune

Although inflation is showing signs of cooling down and the Fed indicated a slower pace of interest rate hikes, recession fears loom. Thanks to the resilient demand for its products and services, the healthcare industry is expected to survive a challenging macroeconomic environment better than many industries. Thus, it could…

StockNews.com

4 Stocks With More Room to Run in 2023

Inflation eased again in November, which could allow the Fed to slow interest-rate hikes into the following year. Overall, the odds of the economy avoiding an anticipated recession are increasing. Given this backdrop, quality stocks CVS Health (CVS), ADT (ADT), ODP Corporation (ODP), and Universal Logistics (ULH) will likely see…

1 … 4 5 6 7

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.